Donna E. Shalala to Discuss the Future of American Medicine at the... businesswire.com/news/home/2013… via Business Wire #BreastCancer #MiamiBreast

hello twitter!

#MiamiBreast leads in presenting #breastcancer topics in an innovative format. It's packed with practical information bit.ly/VR4C6p

Hope you'll give CURE's editor-in-chief a follow and a happy Wednesday! RT Debu Tripathy, MD: hello twitter!

Don't miss the 30th Annual Miami Breast Cancer Conference bit.ly/WYJf8b

In our 30th year Miami Breast #MB2013 will cover info directly relevant to practing medical oncology in #breastcancer bit.ly/VR4C6p

Catch up on recent research on Thursday at #MBCC30 with my talk on #SABCS and #ASCO ow.ly/i8vsO

Great Story! MT @GoToPER #MBCC30 is just around the corner, view the personal story behind the meeting ow.ly/i8ruf

Following Dr Dixon, I'm speaking on risk factors, relative risks, and methods of decreasing risk through lifestyle changes #MBCC30

Hear my review of molecular biology and metastatic, local, and adjuvant therapies from #SABCS and #ASCO12 shortly after 4 PM #MBCC30

Join me in Session B in the Fontaine Room at 2PM for the Medical Oncology Track, the first talk is on the relevance of SLN biopsy #MBCC30

Following the break, the Medical Oncology sessions will enjoy a talk from Dr. Emanuel Petricoin on circulating tumor cells #MBCC30

Following a panel discussion on difficult adjuvant cases, we will adjourn for the day at #MBCC30

We're beginning today's discussions at #MBCC30 with a talk on the affordable care act by Donna Shalala

Great morning sessions. Join me in the Fontaine room for the Medical Oncology Track, beginning at 2 PM #MBCC30

Following the break, in the Fontaine room, Dr. José Baselga will describe deploying new options in HER2-positive #breastcancer #MBCC30

High expression of PD-L1 is independently associated with shorter OS in patients with mRCC receiving VEGF inhibitors ow.ly/tfsPB